KMT2A and acute myeloid leukemia: We found that it inhibited cell growth in multiple cancer cell lines (median IC50 171 nM), with highest potency against AML cell lines derived from patients with MLL translocations (MV4-11, MOLM-13 and THP-1) (Fig. 1B and Additional file 1: Fig. S1A).